These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 27233766

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors.
    Zhou Z, Merkus D, Cheng C, Duckers HJ, Jan Danser AH, Duncker DJ.
    Pharmacol Res; 2013 Jan; 67(1):10-7. PubMed ID: 23063485
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation.
    Zhou Z, de Wijs-Meijler D, Lankhuizen I, Jankowski J, Jankowski V, Jan Danser AH, Duncker DJ, Merkus D.
    Pharmacol Res; 2013 Nov; 77():22-9. PubMed ID: 23994209
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut.
    Durnin L, Hwang SJ, Kurahashi M, Drumm BT, Ward SM, Sasse KC, Sanders KM, Mutafova-Yambolieva VN.
    Proc Natl Acad Sci U S A; 2014 Nov 04; 111(44):15821-6. PubMed ID: 25341729
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors.
    Zhou Z, Sun C, Tilley SL, Mustafa SJ.
    Vascul Pharmacol; 2015 Oct 04; 73():78-85. PubMed ID: 25921923
    [Abstract] [Full Text] [Related]

  • 8. Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.
    Zhou Z, Matsumoto T, Jankowski V, Pernow J, Mustafa SJ, Duncker DJ, Merkus D.
    Pharmacol Res; 2019 Mar 04; 141():32-45. PubMed ID: 30553823
    [Abstract] [Full Text] [Related]

  • 9. Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats.
    Matsumoto T, Tostes RC, Webb RC.
    Am J Physiol Heart Circ Physiol; 2011 Aug 04; 301(2):H409-17. PubMed ID: 21551273
    [Abstract] [Full Text] [Related]

  • 10. Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement.
    Zhou Z, Sorop O, de Beer VJ, Heinonen I, Cheng C, Jan Danser AH, Duncker DJ, Merkus D.
    Purinergic Signal; 2017 Sep 04; 13(3):319-329. PubMed ID: 28540569
    [Abstract] [Full Text] [Related]

  • 11. Activation of adenosine A2A but not A2B receptors is involved in uridine adenosine tetraphosphate-induced porcine coronary smooth muscle relaxation.
    Sun C, Jiao T, Merkus D, Duncker DJ, Mustafa SJ, Zhou Z.
    J Pharmacol Sci; 2019 Sep 04; 141(1):64-69. PubMed ID: 31640919
    [Abstract] [Full Text] [Related]

  • 12. Impaired Aortic Contractility to Uridine Adenosine Tetraphosphate in Angiotensin II-Induced Hypertensive Mice: Receptor Desensitization?
    Zhou Z, Yadav VR, Sun C, Teng B, Mustafa JS.
    Am J Hypertens; 2017 Mar 01; 30(3):304-312. PubMed ID: 28034895
    [Abstract] [Full Text] [Related]

  • 13. Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice.
    Teng B, Labazi H, Sun C, Yang Y, Zeng X, Mustafa SJ, Zhou Z.
    Purinergic Signal; 2017 Dec 01; 13(4):591-600. PubMed ID: 28929376
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fibulin-7 is overexpressed in glioblastomas and modulates glioblastoma neovascularization through interaction with angiopoietin-1.
    de Vega S, Kondo A, Suzuki M, Arai H, Jiapaer S, Sabit H, Nakada M, Ikeuchi T, Ishijima M, Arikawa-Hirasawa E, Yamada Y, Okada Y.
    Int J Cancer; 2019 Oct 15; 145(8):2157-2169. PubMed ID: 30924128
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates.
    Jankowski V, Schulz A, Kretschmer A, Mischak H, Boehringer F, van der Giet M, Janke D, Schuchardt M, Herwig R, Zidek W, Jankowski J.
    J Mol Med (Berl); 2013 Sep 15; 91(9):1095-107. PubMed ID: 23636508
    [Abstract] [Full Text] [Related]

  • 18. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors.
    Brudno Y, Ennett-Shepard AB, Chen RR, Aizenberg M, Mooney DJ.
    Biomaterials; 2013 Dec 15; 34(36):9201-9. PubMed ID: 23972477
    [Abstract] [Full Text] [Related]

  • 19. P2Y purinoceptors as potential emerging therapeutical target in vascular disease.
    Schuchardt M, Tölle M, van der Giet M.
    Curr Pharm Des; 2012 Dec 15; 18(37):6169-80. PubMed ID: 23004340
    [Abstract] [Full Text] [Related]

  • 20. Dynamic mass redistribution assays decode surface influence on signaling of endogenous purinergic P2Y receptors.
    Tran E, Sun H, Fang Y.
    Assay Drug Dev Technol; 2012 Feb 15; 10(1):37-45. PubMed ID: 22066912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.